RGNX : Insider Transactions for Regenxbio Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Regenxbio Inc. (RGNX)

$14.92

0.04 (0.27%) as of 4:30 Fri 5/24

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

43,990,000

Market Cap:

656.33(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$12.17 - $24.61

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile REGENXBIO is a clinical-stage biotechnology company. Co.'s product candidates include: RGX-314, which is being developed as a gene therapy for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other additional chronic retinal conditions which cause total or partial vision loss for patients in the U.S., Europe and Japan; RGX-121, which is for the treatment of Mucopolysaccharidosis Type II; RGX-111, which is for the treatment of Mucopolysaccharidosis Type I; RGX-181, which is for the treatment of late infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease; and RGX-381, which is for the treatment of ocular manifestations of CLN2 disease.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	57,878	180,115	180,115	210,533
Total Sell Value	$1,203,255	$3,323,210	$3,323,210	$4,306,417
Total People Sold	2	2	2	3
Total Sell Transactions	4	8	8	15
End Date	2024-02-25	2023-11-24	2023-05-26	2022-05-26

Adjust Filter Settings

Records found: 406

Page 15 of 17

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Chief Medical Officer

• – –

2017-07-20

4

AS

$18.66

$279,900

D/D

(15,000)

0

-

Chief Medical Officer

• – –

2017-07-20

4

OE

$0.85

$12,750

D/D

15,000

15,000

-

Chief Financial Officer

• – –

2017-07-17

4

AS

$19.81

$61,411

D/D

(3,100)

105,323

-

Christmas Patrick J.

SVP, General Counsel

• – –

2017-06-30

4

A

$15.73

$10,300

D/D

655

655

-

Chief Financial Officer

• – –

2017-06-30

4

A

$15.73

$14,325

D/D

911

108,423

-

Mills Kenneth T.

President and CEO

• • –

2017-06-20

4

AS

$19.60

$127,902

D/D

(6,500)

118,500

-

Chief Medical Officer

• – –

2017-06-20

4

AS

$19.61

$295,157

D/D

(15,000)

0

-

Chief Medical Officer

• – –

2017-06-20

4

OE

$0.85

$12,750

D/D

15,000

15,000

-

Chief Financial Officer

• – –

2017-06-15

4

AS

$18.75

$58,125

D/D

(3,100)

107,512

-

Chief Financial Officer

• – –

2017-05-15

4

AS

$19.07

$59,117

D/D

(3,100)

110,612

-

Hayden Donald J Jr

Director

– • –

2017-05-15

4

AS

$19.04

$163,725

D/D

(8,599)

0

-

Hayden Donald J Jr

Director

– • –

2017-05-08

4

AS

$18.35

$183,500

D/D

(10,000)

8,599

-

Hayden Donald J Jr

Director

– • –

2017-05-01

4

AS

$21.34

$667,736

D/D

(30,000)

18,599

-

Hayden Donald J Jr

Director

– • –

2017-05-01

4

OE

$0.85

$17,000

D/D

20,000

48,599

-

Mills Kenneth T.

President and CEO

• • –

2017-04-24

4

AS

$20.94

$323,955

D/D

(15,440)

125,000

-

Hayden Donald J Jr

Director

– • –

2017-04-24

4

AS

$20.98

$209,800

D/D

(10,000)

28,599

-

Chief Financial Officer

• – –

2017-04-24

4

AS

$20.95

$65,099

D/D

(3,100)

113,712

-

SVP, Technical Operations

• – –

2016-12-08

4

A

$0.00

$0

D/D

39,500

39,500

-

Mills Kenneth T.

President and CEO

• • –

2016-06-13

4

OE

$0.85

$106,250

D/D

125,000

140,440

-

See Remark 1

– – –

2016-05-17

4

D

$0.00

$0

I/I

(129,496)

489,880

-

See Remark 1

– – –

2016-05-17

4

S

$12.41

$227,103

I/I

(18,300)

619,376

-

See Remark 1

– – •

2016-05-16

4

S

$11.69

$124,534

I/I

(10,500)

637,676

-

See Remark 1

– – •

2016-05-13

4

S

$11.25

$62,231

I/I

(5,530)

648,176

-

See Remark 1

– – •

2016-05-12

4

S

$10.83

$72,833

I/I

(6,711)

653,706

-

See Remark 1

– – •

2016-05-11

4

S

$10.28

$150,135

I/I

(14,189)

660,417

-

406 Records found	Previous 10 11 12 13 14 15 16 17	Page 15 of 17

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.